Splicing inhibition induces gene expression through canonical NF-κB pathway and extracellular signal-related kinase activation

FEBS Lett. 2014 Mar 18;588(6):1053-7. doi: 10.1016/j.febslet.2014.02.018. Epub 2014 Feb 20.

Abstract

Splicing, a process for mRNA maturation, is essential for correct gene expression after transcription. However, recent studies also suggest that splicing affects transcription, but its mechanism remains elusive. We previously reported that treatment with spliceostatin A (SSA), a specific splicing inhibitor targeting the splicing factor SF3b, leads to transcriptional activation of a small subset of genes. To investigate the underlying mechanism we utilized luciferase reporters driven by the Interleukin 8 (IL-8) and cytomegalovirus (CMV) promoters, as both recruit a similar set of transcription factors. We also found that SSA treatment led to increased extracellular signal-regulated protein kinase (ERK) activity and that chemical inhibition of ERK also led to decreased promoter activation. Systematic deletion studies suggested that NF-κB activation is mainly responsible for SSA-induced promoters activation.

Keywords: Extracellular signal-regulated protein kinase; NF-κB; Spliceostatin A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytomegalovirus / genetics
  • Enzyme Activation
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Gene Expression*
  • Genes, Reporter
  • HeLa Cells
  • Humans
  • I-kappa B Proteins / metabolism
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism
  • Luciferases / biosynthesis
  • Luciferases / genetics
  • MAP Kinase Signaling System
  • Mice
  • NF-KappaB Inhibitor alpha
  • NIH 3T3 Cells
  • Promoter Regions, Genetic
  • Pyrans / pharmacology
  • RNA Splicing / drug effects*
  • Spiro Compounds / pharmacology
  • Transcription Factor RelA / metabolism*

Substances

  • I-kappa B Proteins
  • Interleukin-8
  • NFKBIA protein, human
  • Nfkbia protein, mouse
  • Pyrans
  • RELA protein, human
  • Spiro Compounds
  • Transcription Factor RelA
  • spliceostatin A
  • NF-KappaB Inhibitor alpha
  • Luciferases
  • Extracellular Signal-Regulated MAP Kinases